| 000 | 01606 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517073304.0 | ||
| 264 | 0 | _c20161213 | |
| 008 | 201612s 0 0 eng d | ||
| 022 | _a1573-7373 | ||
| 024 | 7 |
_a10.1007/s11060-015-2039-z _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWu, Xing | |
| 245 | 0 | 0 |
_aPrognostic significance of stem cell marker CD133 determined by promoter methylation but not by immunohistochemical expression in malignant gliomas. _h[electronic resource] |
| 260 |
_bJournal of neuro-oncology _cApr 2016 |
||
| 300 |
_a221-32 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAC133 Antigen _xgenetics |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xgenetics |
| 650 | 0 | 4 |
_aBrain Neoplasms _xgenetics |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aDNA Methylation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aGlioma _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunoenzyme Techniques |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Grading |
| 650 | 0 | 4 |
_aNeoplastic Stem Cells _xmetabolism |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aPromoter Regions, Genetic _xgenetics |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aWu, Fenlang | |
| 700 | 1 | _aXu, Dongwen | |
| 700 | 1 | _aZhang, Tao | |
| 773 | 0 |
_tJournal of neuro-oncology _gvol. 127 _gno. 2 _gp. 221-32 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s11060-015-2039-z _zAvailable from publisher's website |
| 999 |
_c25622780 _d25622780 |
||